Stock Scorer
Stock Board CompareNew Screen
Donate
…
Report Measures Companies
Sign in

These figures are from 2024-12-31. Nothing newer has been filed for EUROFINS SCIENTIFIC SE in the 20 months since, so the score below is built on that year and not on the company as it stands today. Everything here is still the company's own filing, unchanged — every figure against the element it came from.

EUROFINS SCIENTIFIC SE (ERF.PA)

No price history is stored for ERF.PA, so there is no chart to draw. Every figure below is read from the filings and does not depend on one.

Financials Annual

Figures
Revenue Gross Profit Operating Income Cost of Revenue Operating Cash Flow Free Cash Flow Net Income

A share count and earnings a share are not here: neither is money, so neither can share this axis. Both have their own panel on All charts.

All charts ›

EUROFINS SCIENTIFIC SE reported revenue of 7B EUR for the year ending 31 December 2024, up 6.7% from 6.5B a year earlier. Every figure, period by period ›

FY20 — Revenue: 5.4B FY20 — Operating Cash Flow: 1.2B FY20 — Free Cash Flow: 912.7M FY20 — Net Income: 540.5M FY21 — Revenue: 6.7B FY21 — Operating Cash Flow: 1.5B FY21 — Free Cash Flow: 1.1B FY21 — Net Income: 783M FY22 — Revenue: 6.7B FY22 — Operating Cash Flow: 1.1B FY22 — Free Cash Flow: 560.2M FY22 — Net Income: 605.8M FY23 — Revenue: 6.5B FY23 — Operating Cash Flow: 1B FY23 — Free Cash Flow: 539.8M FY23 — Net Income: 307.8M FY24 — Revenue: 7B FY24 — Operating Cash Flow: 1.3B FY24 — Free Cash Flow: 865.3M FY24 — Net Income: 405.5M 0 1.5B 3B 4.5B 6B 7.5B
FY20 FY21 FY22 FY23 FY24
Revenue Operating Cash Flow Free Cash Flow Net Income

How it scores

For a valuation multiple, the low end is the good end.

Quality

How much of the revenue is really kept — and what did it take to earn it?

4.5
Accruals -8.4%
SBC / sales 0.0%
OCF / EBIT 1.9×
Capex / sales 6.5%
DSO 57.5 days
OCF margin 19.0%
OE margin 12.4%
Asset turnover 0.64×
FCF margin 12.4%
ROCE 7.8%
Adj. EBITDA margin 9.8%
Oper. margin 9.8%
Profit margin 5.8%
ROE 7.6%
ROIC 6.8%
ROA 3.7%

16 of 19 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Valuation

What does the price ask for what the company earns, owns and pays out?

0.5

0 of 12 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Durability

How predictable is the revenue, and how much of it is already committed?

6.8
Cash-flow margin stability 2.8 pp
Revenue growth in the worst year on record -2.9%

2 of 7 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Resilience

Can the balance sheet absorb a bad year?

5.2
F-score 7.7 pts
Retained / assets 24.7%
Net debt / Eq 0.47×
Payout 24.2%
Equity / Assets 49.0%
Debt / Eq 0.59×
Debt payback 2.9 yr
Cash / Debt 0.2×
Quick ratio 1.1×
Interest cover 4.5×
Current ratio 1.2×

12 of 13 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Growth

Is the business getting bigger, and is it getting more profitable?

2.8
Most recent margin move 2.2
EPS Y/Y +31.7%
EBIT Y/Y +28.4%
Sales/sh Y/Y +6.7%
Sales CAGR 4Y +6.3%
Operating margin trend -1.2
EBIT CAGR -4.0%
EPS CAGR 4Y -6.6%
Div. growth -49.2%

9 of 13 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

A measure absent from a block could not be computed from this company's filings. It is left out rather than scored as though it were bad, and the dimension is averaged over what remains. A score is measured against a fixed scale this model states; the bar is measured against the other companies, so the two can disagree — and where they do, that disagreement is the more interesting figure.